Cooperative AgreementPostedDiscretionary

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

National Institutes of Health
RFA-AI-28-013
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding
$36,000,000

Grant Opportunity Analysis

The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, is seeking to provide resources, staff, and facilities support for the Regional Biocontainment Laboratories. Funded activities include facility maintenance, operations, and biocontainment-specific training to sustain a capable biosafety level 3 workforce in the United States. This limited competition is open only to twelve specified universities hosting these facilities to support biosafety level 2 and 3 biocontainment capabilities for infectious disease research and public health emergency response. Applications will undergo standard NIH peer-review processes, and the program anticipates awarding an estimated total of $36,000,000 across approximately 12 cooperative agreements starting in August 2028. For inquiries, organizations can contact the agency at NIAIDRBL-NBL@mail.nih.gov ahead of the estimated September 30, 2027 closing date.

Eligible Applicants

Private Institutions of Higher Education
Additional Eligibility Information

Eligible ApplicantsUniversity of Alabama at BirminghamTulane UniversityUniversity of TennesseeGeorge Mason UniversityDuke UniversityRutgers UniversityTufts UniversityUniversity of PittsburghUniversity of ChicagoUniversity of MissouriUniversity of LouisvilleColorado State University

Grant Documents

0 Files
No grant documents

No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedJun 24, 2026

Funding Details

Est. Total Program Funding
$36,000,000
Expected Awards
12
No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
NIAID RBL-NBL (Division of Microbiology and Infectious Diseases)

CFDA Numbers

93.855

Official Sources